In vitro comparison of two bioartificial liver support systems: MELS CellModule and AMC-BAL

International Journal of Artificial Organs

Volumn 30, Issue 3, 2007, Pages 183-191

  Poyck, P P C ^a   Pless, G ^b   Hoekstra, R ^a   Roth, S ^b   Van Wijk, A C W A ^a   Schwartlander R ^b   Van Gulik, T M ^a   Sauer, I M ^b   Chamuleau, R A F M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

AMC BAL; Bioartificial liver; Bioreactor, Extracorporeal liver support; Hepatocytes; Hybrid liver; Liver failure; MELS CellModule

Indexed keywords

BIOREACTORS;

AMC-BIOARTIFICIAL LIVER; BIOARTIFICIAL LIVER; BIOREACTOR, EXTRACORPOREAL LIVER SUPPORT; HEPATOCYTES; HYBRID LIVER; IN-VITRO; LIVER FAILURE; MODULAR EXTRACORPOREAL LIVER SUPPORT CELLMODULE; MODULARS;

ARTIFICIAL ORGANS;

AMMONIA; LACTATE DEHYDROGENASE; LIDOCAINE;

ANIMAL CELL; ARTICLE; BIOARTIFICIAL LIVER; BIOREACTOR; CELL FUNCTION; CELL ISOLATION; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME RELEASE; FEMALE; IN VITRO STUDY; LIVER CELL CULTURE; LIVER SUPPORT; NONHUMAN; SWINE;

EID: 34248350050     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880703000302     Document Type: Article

References (17)

1. Matsumura KN, Guevara GR, Huston H, Hamilton WL, Rikimaru M, Yamasaki G, Matsumura MS. Hybrid bioartificial liver in hepatic failure: Preliminary clinical report. Surgery 1987; 101: 99-103.
2. Jalan R, Hayes PC. Hepatic encephalopathy and ascites. Lancet 1997; 350: 1309-15.
3. van de Kerkhove MP, Poyck PP, van Wijk AC, Galavotti D, Hoekstra R, van Gulik TM, Chamuleau RA. Assessment and improvement of liver specific function of the AMC-bioartificial liver. Int J Artif Organs 2005; 28: 617-30.
4. Sauer IM, Kardassis D, Zeillinger K, Pascher A, Gruenwald A, Pless G, Irgang M, Kraemer M, Puhl G, Frank J, Muller AR, Steinmuller T, Denner J, Neuhaus P, Gerlach JC. Clinical extracorporeal hybrid liver support-phase I study with primary porcine liver cells. Xenotransplantation 2003; 10: 460-9.
5. Sauer IM, Zeilinger K, Obermayer N, Pless G, Grunwald A, Pascher A, Mieder T, Roth S, Goetz M, Kardassis D, Mas A, Neuhaus P, Gerlach JC. Primary human liver cells as source for modular extracorporeal liver support - a preliminary report. Int J Artif Organs 2002; 25: 1001-5.
6. van de Kerkhove MP, Di Florio E, Scuderi V, Mancini A, Belli A, Bracco A, Dauri M, Tisone G, Di Nicuolo G, Amoroso P, Spadari A, Lombardi G, Hoekstra R, Calise F, Chamuleau RA. Phase I clinical trial with the AMC-bioartificial liver. Academic Medical Center. Int J Artif Organs 2002; 25: 950-9.
7. van de Kerkhove MP, Hoekstra R, Chamuleau RA, van Gulik TM. Clinical application of bioartificial liver support systems. Ann Surg 2004; 240: 216-30.
8. Park JK, Lee DH. Bioartificial liver systems: Current status and future perspective. J Biosci Bioeng 2005; 99: 311-9.
9. Gerlach JC, Botsch M, Kardassis D, Lemmens P, Schon M, Janke J, Puhl G, Unger J, Kraemer M, Busse B, Bohmer C, Belal R, Ingenlath M, Kosan M, Kosan B, Sultmann J, Patzold A, Tietze S, Rossaint R, Muller C, Monch E, Sauer IM, Neuhaus F. Experimental evaluation of a cell module for hybrid liver support. Int J Artif Organs 2001; 24: 793-8.
10. Flendrig LM, Chamuleau RA, Maas MA, Daalhuisen J, Hasset B, Kilty CG, Doyle S, Ladiges NC, Jorning GG, la Soe JW, Sommeijer D, to Velde AA. Evaluation of a novel bioartificial liver in rats with complete liver ischemia: Treatment efficacy and species-specific alpha-GST detection to monitor hepatocyte viability. J Hepatol 1999; 30: 311-20.
11. Flendrig LM, Calise F, Di Florio E, Mancini A, Ceriello A, Santaniello W, Mezza E, Sicoli F, Belleza G, Bracco A, Cozzolino S, Scala D, Mazzone M, Fattore M, Gonzales E, Chamuleau RA. Significantly improved survival time in pigs with complete liver ischemia treated with a novel bioartificial liver. Int J Artif Organs 1999; 22: 701-9.
12. Sosef MN, Abrahamse LS, van de Kerkhove MP, Hartman R, Chamuleau RA, van Gulik TM. Assessment of the AMC-bioartificial liver in the anhepatic pig. Transplantation 2002; 73: 204-9.
13. Seglen PO. Preparation of rat liver cells. 3. Enzymatic requirements for tissue dispersion. Exp Cell Res 173; 82: 391-8.
14. Catapano G. Mass transfer limitations to the performance of membrane bioartificial liver support devices. Int J Artif Organs 1996; 19:1 8-35.
15. Tzanakakis ES, Hess DJ, Sielaff TD, Hu WS. Extracorporeal tissue engineered liver-assist devices. Annu Rev Biomed Eng 2000; 2: 607-32.
16. Poyck PP, Hoekstra R, van Wijk AC, Ten Bloemendaal L, Chamuleau RA, van Gulik TM. Mild hypothermic preservation for transport purposes of the AMC bioartificial liver charged with porcine hepatocytes. Transplantation 2005; 80: 1153-60.
17. Sauer IM, Schwartlander R, van der Jagt O, Steffen I, Efimova E, Pless G, Kehr DC, Kardassis D, Fruhauf JH, Gerlach JC, Neuhaus P. In vitro evaluation of the transportability of viable primary human liver cells originating from discarded donor organs in bioreactors. Artif Organs 2005; 29: 144-51.